2nd Annual Multidisciplinary Cardiac Sarcoidosis Symposium

Friday, March 3, 2023


This conference has already taken place.


The Ohio State University Wexmer Medical Center - Columbus, OH
1 Day Conference March 3rd, 2023
3.75 AMA PRA Category 1 Credit Hours

Description

Cardiac sarcoidosis is a rare autoimmune disorder that causes cells to clump together into granulomas that disrupt heart function. It's a variation of sarcoidosis. Cardiac sarcoidosis can mimic other conditions and go undiagnosed for years. As a result, there is a gap in knowledge when selecting medications, testing modalities, especially the use of imaging, completing physical assessments and risk stratification, when to refer patients, utilization of current treatment strategies and clinical trials for this condition.  This symposium is available for in-person and online participation.

Dates and Times

Start: 3/3/2023 8:00 AM
End: 3/3/2023 12:00 PM

Objectives

At the conclusion of this activity, participants should be able to:
1. Recognize the role of PET and MRI for diagnosis of cardiac sarcoidosis.
2. Review the role serum biomarkers for the diagnosis of cardiac sarcoidosis.
3. Identify the role of prolonged ambulatory rhythm monitoring for cardiac sarcoidosis.
4. Discuss risk stratification for pacing and defibrillation therapy.
5. Explain the role of immunosuppressants for the treatment of cardiac sarcoidosis.
6. Describe the management of ventricular arrhythmia in patients with cardiac sarcoidosis.
7. Review surveillance for long-term complications of cardiac sarcoidosis.
8. Discuss the association of cardiac sarcoidosis and advanced heart failure and pulmonary hypertension.
9. Describe the multidisciplinary approach for management of cardiac sarcoidosis.

Agenda

Session 1: Diagnostic Evaluation of Cardiac sarcoidosis -Moderator
                                       
Moderator: Ayesha Hasan, MD
8:00 am     Multidisciplinary approach for management of cardiac sarcoidosis
                                      Ayesha Hasan, MD
8:10           When do you suspect and refer for evaluation of cardiac sarcoidosis
                                      Arindam Singha, MD
8:25           Clinical use of PET during diagnosis and treatment: Clinician’s perspective
                                      Vaiibhav Patel, MD
8:40           Clinically useful lab test for diagnosis/surveillance of cardiac sarcoidosis
                                      Elliott Crouser, MD
8:55           Q & A

Session 2: Risk stratification in Cardiac Sarcoidosis

                                      Moderator: Steven Kalbfleisch, MD
9:05            Role of cardiac MRI for diagnosis and risk stratification of cardiac sarcoidosis – an Imager’s perspective
                                      Karolina Zareba, MD
9:20            Implications of finding high burden PVCs, NSVT or atrial arrhythmias during ambulatory monitoring.
                                     Jordana Kron, MD
9:35            Risk stratification - Determining who with cardiac sarcoid requires device therapy
                                     Steven Kalbfleisch, MD
9:50          Q & A

Session 3: Surveillance/ Clinical follow-up

                                     Moderator: Elliot Crouser, MD
10:00          Non-cardiac sarcoidosis: What a cardiologist needs to know? who should do this?
                                     Eli Homsy, MD
10:15          Sarcoid trials – Purpose / importance of the trials, CHASM trial update
                                     David Birnie, MD
10:30          Role of arrhythmia monitoring during cardiac sarcoidosis during follow up
                                    Muhammad Afzal, MD
10:45           Q & A

Session 4: Clinical management of complications of cardiac sarcoidosis
                                   Moderator: Rami Kahwash, MD
11:00          Management of HF in cardiac sarcoidosis
                                   Gaurang Vaidya, MD
11:15          Role of immunosuppressants for treatment of arrhythmias in cardiac sarcoidosis
                                   Rami Kahwash, MD
11:30          Management of sustained VT: immunosuppressant vs AADx vs catheter ablation vs sympathectomy:/SBRT
                                   Toshimasa Okabe MD
11:45          Q & A
11:55          Closing Remarks
                                   Steven Kalbfleisch, MD

Pricing

Tier Price
Physician, participating in person $0.00
Physician, participating online $0.00
Nurse/Nurse Practitioner, participating in person $0.00
Nurse/Nurse Practitioner, participating online $0.00
Allied Medical Professional, participating in person $0.00
Allied Medical Professional, participating online $0.00
Other, participating in person $0.00
Other, participating online $0.00

Speakers

  • Dr. Muhammad Afzal, MBBS
    • Role of arrhythmia monitoring during cardiac sarcoidosis during follow up
  • Dr. David Birnie, MD
    • Sarcoid trials – Purpose / importance of the trials, CHASM trial update
  • Dr. Elliott Crouser, MD
    • Clinically useful lab test for diagnosis/surveillance of cardiac sarcoidosis
  • Dr. Ayesha Hasan, MD
    • Multidisciplinary approach for management of cardiac sarcoidosis
  • Dr. Rami Kahwash, MD
    • Role of immunosuppressants for treatment of arrhythmias in cardiac sarcoidosis
  • Dr. Steven Kalbfleisch, MD
    • Risk stratification - Determining who with cardiac sarcoid requires device therapy
  • Dr. Jordana Kron, MD
    • Implications of finding high burden PVCs, NSVT or atrial arrhythmias during ambulatory monitoring
  • Dr. Toshimasa Okabe, MD
    • Management of sustained VT: immunosuppressant vs AADx vs catheter ablation vs sympathectomy:/SBRT
  • Dr. Vaiibhav Patel, MD
    • Clinical use of PET during diagnosis and treatment: Clinician’s perspective
  • Dr. Arindam Singha, MD
    • When do you suspect and refer for evaluation of cardiac sarcoidosis
  • Dr. Gaurang Vaidya, MD
    • Management of HF in cardiac sarcoidosis
  • Dr. Karolina Zareba, MD
    • Role of cardiac MRI for diagnosis and risk stratification of cardiac sarcoidosis – an Imager’s perspective

Location

The Ohio State University Wexmer Medical Center
Biomedical Research Tower
460 W. 12th AVenue
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this conference?

Please contact the conference coordinator listed below:

Ellen Yokoyama
Department: Heart and Vascular Center
Phone: (614) 293-7161
Email: Ellen.Yokoyama@osumc.edu